感染性心内膜炎.ppt
http://www.100md.com
参见附件(66KB)。
Update on
Infective Endocarditis
Larry Baddour, MD
University of Tennessee
Pathogenesis
? Disruption of the endocardial layer as a complication of abnormal blood flow associated with underlying cardiac defect
? Bacterium-endothelium interaction with bacterial attachment and invasion of endothelial cells
Epidemiology
? Underlying valvular abnormality predisposing to infective endocarditis
- rheumatic fever
a common cause in the past
- mitral valve prolapse
currently represents the most common underlying cardiac abnormality
mitral valve prolapse
? risk for infective ednocarditis is ?5x-8x
? mitral regurgitation increases the risk
? leaflet redundancy with myxomatous degeneration is a frequent finding
? age <20 , female predominate
age >20 , male accounts for 60%
age >50 , male accounts for 68%
Mitral Valve Prolapse
and Infective Endocarditis
Coagulase-negative Staphylococci
? can produce native-valve endocarditis in mitral valve prolapse
? usually subacute, difficult to diagnose, and disregarded as a contaminant
? delay in diagnosis and treatment may account for the severe complications
- myocardial abscess formation
- valvular insufficiency requiring valve surgery
- death
Prosthetic Heart Valve
? positive blood culture in hospitalized patients with underlying prosthetic valves can be a harbinger of endocarditis
? 43% patients with nosocomial bacteremia or fungemia had prosthetic valve infection
? a serious complication
IV Drug Use
? Recurrent
? Polymicrobial
? Staph aureus accounts for the majority of cases of endocarditis
? tricuspid valve, either alone or in combination, us most often infected
Predisposing Factors Polymicrobial Infective Endocarditis
Polymicrobial Infective Endocarditis
clinical features
? IV drug use is the predominant risk factor
? younger age (mean 36.5 years)
? 2/3 were male
? right-sided cardiac involvement in > 60%
? streptococci more frequent than S. aureus
? 1/3 of patients died
? mortality rate is 4x higher for pure left-sides vs pure right-sided endocarditis
Diagnostic (Duke) Criteria
? Definitive infective endocarditis
- pathologic criteria
? microorganisms or pathologic lesions: demonstrated by culture or histology in a vegetation, or in a vegetation that has embolized, or in an intracardiac abscess
- clinical criteria (see below)
? two major criteria, or one major and three minor criteria, or five minor criteria
Diagnostic (Duke) Criteria
? Possible infective endocarditis
- findings consistent of IE that fall short of "definite", but not "rejected"
? Rejected
- firm alternate Dx for manifestation of IE
- resolution ofmanifestations of IE, with antibiotic therapy for ? 4 days
- no pathologic evidence of IE at surgery or autopsy, after antibiotic therapy for ? 4 days
Diagnostic (Duke) Criteria
? Major criteria
- positive blood culture for IE
- evidence of endocardial involvement
? Minor criteria
- predisposition (heart condition or IV drug use)
- fever of 100.40F or higher
- vascular or immunologic phenomena
- microbiologic or echocardiographic evidence not meeting major criteria
Duke's Major Criteria
? positive blood culture for IE
- typical microorganism (strep viridans, strep bovis, HACEK group, staph aureus or enterococci in the absence of a primary locus) for endocarditis from two separate blood cultures
- persistently positive blood culture from:
? blood cultures drawn more than 12 hr apart, or
? all of 3 or a majority of 4 or more separate blood cultures, with first and last drqwn at least 1 hr apart
Duke's Major Criteria
? Evidence of endocardial involvement
- positive echocardiogram for endocarditis
? oscillating intracardiac mass on valve or supporting structure, or in the path of regurgitant jets, or on implanted material, in the absence of an alternate anatomic explanation
? abscess
? new partial dehiscence of prosthetic valve
- new valvular regurgitation (increase or change in pre-existing murmur not sufficient)
Duke's Minor Criteria
? predisposition (predisposing heart condition or iv drug use)
? fever of 100.40F or higher
? vascular phenomena (major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctive hemorrhages, Janeway lesions)
Duke's Minor Criteria
? immunologic phenomena (glomerulonephritis, Osler's nodes, Roth spots, rheumatoid factor)
? microbiologic evidence (positive blood culture not meeting major criteria or serologic evidence of active infection with organism consistent with IE)
? echocardiogram (consistent with IE but not meeting major criteria)
Risk for Endocarditis
? High risk
- prosthetic cardiac valve
- prior episodes of endocarditis
- complex congenital cardiac defect
- surgically constructed systemic-pulmonary shunts or conduits
Risk for Endocarditis
? Moderate risk
- patent ductus arteriosus
- VSD, primum ASD
- coarctation of the aorta
- bicuspid aortic valve
- hypertrophic cardiomyopathy
- acquired valvular dysfunction
- MVP with mitral regurgitation
Risk for Endocarditis
? Low risk
- isolated secundum atrial septal defect
- ASD, VSD, or PDA >6 months past repair
- "innocent" heart murmur by auscultation in the pediatric population
- "innocent" heart murmur by echocardiography in adult patients
Treatment
? Pre-antibiotic era - a death sentence
? Antibiotic era
- microbiologic cure in majority of patients
New Treatments
? Right-sided infective endocarditis due to methicillin-susceptible S aureus (MSSA) in IV drug users
- 2-wk therapy with a penicillinase-resistant penicillin and an aminoglycoside
- 2-wk monotherapy with IV cloxacillin
- short-term therapy is inappropriate if complicated by ostomyelitis, meningitis, myocardial abscess, or concomitant left-sided involvement
New Treatments
? Highly penicillin-susceptible Streptococcus viridans or bovis
- Once-daily ceftriaxone for 4 wks
? cure rate > 98%
? easily administered as outpatient, avoid hospitalization, offers significant cost savings
- Once-daily ceftriaxone 2 g for 2wks followed by oral amoxicillin qid for 2 wks
- Once-daily ceftriazone and netilmicin for 2 wks
New Treatments
? Prosthetic valve endocarditis due to fluconazole-susceptible Candida species
- many are due to bloodstream invasion
- chronic oral suppressive therapy with fluconazole for inoperable disease
SBE Prophylaxis
Standard general prophylaxisamoxicillin
Unable to take oral medsampicillin
Allergic to penicilinclindamycin
cephalexin
azithromycin
clarithromycin
Allergic to penicillin and unableclindamycin
to take oral medicationscefazolin
References
? Prevention of bacterial endocarditis.Recommended by the American Heart Association.
Dajani AS, Taubert KA, Wilson W, et al. Circulation 1997;96:358-366
? New Criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings.
Durack DT, Lukes AS, Bright DK, et al.Am J Med 1994;96:200-209
? Antibiotic treatment of adults with infective endocarditis due to strptococci, enterococci, staphlococci, and HACEK microorganisms.Wilson WR, Karchmer AW, Dajani AS. JAMA 1995;274:1706-1713
Update on
Infective Endocarditis
Larry Baddour, MD
University of Tennessee
Pathogenesis
? Disruption of the endocardial layer as a complication of abnormal blood flow associated with underlying cardiac defect
? Bacterium-endothelium interaction with bacterial attachment and invasion of endothelial cells
Epidemiology
? Underlying valvular abnormality predisposing to infective endocarditis
- rheumatic fever
a common cause in the past
- mitral valve prolapse
currently represents the most common underlying cardiac abnormality
mitral valve prolapse
? risk for infective ednocarditis is ?5x-8x
? mitral regurgitation increases the risk
? leaflet redundancy with myxomatous degeneration is a frequent finding
? age <20 , female predominate
age >20 , male accounts for 60%
age >50 , male accounts for 68%
Mitral Valve Prolapse
and Infective Endocarditis
Coagulase-negative Staphylococci
? can produce native-valve endocarditis in mitral valve prolapse
? usually subacute, difficult to diagnose, and disregarded as a contaminant
? delay in diagnosis and treatment may account for the severe complications
- myocardial abscess formation
- valvular insufficiency requiring valve surgery
- death
Prosthetic Heart Valve
? positive blood culture in hospitalized patients with underlying prosthetic valves can be a harbinger of endocarditis
? 43% patients with nosocomial bacteremia or fungemia had prosthetic valve infection
? a serious complication
IV Drug Use
? Recurrent
? Polymicrobial
? Staph aureus accounts for the majority of cases of endocarditis
? tricuspid valve, either alone or in combination, us most often infected
Predisposing Factors Polymicrobial Infective Endocarditis
Polymicrobial Infective Endocarditis
clinical features
? IV drug use is the predominant risk factor
? younger age (mean 36.5 years)
? 2/3 were male
? right-sided cardiac involvement in > 60%
? streptococci more frequent than S. aureus
? 1/3 of patients died
? mortality rate is 4x higher for pure left-sides vs pure right-sided endocarditis
Diagnostic (Duke) Criteria
? Definitive infective endocarditis
- pathologic criteria
? microorganisms or pathologic lesions: demonstrated by culture or histology in a vegetation, or in a vegetation that has embolized, or in an intracardiac abscess
- clinical criteria (see below)
? two major criteria, or one major and three minor criteria, or five minor criteria
Diagnostic (Duke) Criteria
? Possible infective endocarditis
- findings consistent of IE that fall short of "definite", but not "rejected"
? Rejected
- firm alternate Dx for manifestation of IE
- resolution ofmanifestations of IE, with antibiotic therapy for ? 4 days
- no pathologic evidence of IE at surgery or autopsy, after antibiotic therapy for ? 4 days
Diagnostic (Duke) Criteria
? Major criteria
- positive blood culture for IE
- evidence of endocardial involvement
? Minor criteria
- predisposition (heart condition or IV drug use)
- fever of 100.40F or higher
- vascular or immunologic phenomena
- microbiologic or echocardiographic evidence not meeting major criteria
Duke's Major Criteria
? positive blood culture for IE
- typical microorganism (strep viridans, strep bovis, HACEK group, staph aureus or enterococci in the absence of a primary locus) for endocarditis from two separate blood cultures
- persistently positive blood culture from:
? blood cultures drawn more than 12 hr apart, or
? all of 3 or a majority of 4 or more separate blood cultures, with first and last drqwn at least 1 hr apart
Duke's Major Criteria
? Evidence of endocardial involvement
- positive echocardiogram for endocarditis
? oscillating intracardiac mass on valve or supporting structure, or in the path of regurgitant jets, or on implanted material, in the absence of an alternate anatomic explanation
? abscess
? new partial dehiscence of prosthetic valve
- new valvular regurgitation (increase or change in pre-existing murmur not sufficient)
Duke's Minor Criteria
? predisposition (predisposing heart condition or iv drug use)
? fever of 100.40F or higher
? vascular phenomena (major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctive hemorrhages, Janeway lesions)
Duke's Minor Criteria
? immunologic phenomena (glomerulonephritis, Osler's nodes, Roth spots, rheumatoid factor)
? microbiologic evidence (positive blood culture not meeting major criteria or serologic evidence of active infection with organism consistent with IE)
? echocardiogram (consistent with IE but not meeting major criteria)
Risk for Endocarditis
? High risk
- prosthetic cardiac valve
- prior episodes of endocarditis
- complex congenital cardiac defect
- surgically constructed systemic-pulmonary shunts or conduits
Risk for Endocarditis
? Moderate risk
- patent ductus arteriosus
- VSD, primum ASD
- coarctation of the aorta
- bicuspid aortic valve
- hypertrophic cardiomyopathy
- acquired valvular dysfunction
- MVP with mitral regurgitation
Risk for Endocarditis
? Low risk
- isolated secundum atrial septal defect
- ASD, VSD, or PDA >6 months past repair
- "innocent" heart murmur by auscultation in the pediatric population
- "innocent" heart murmur by echocardiography in adult patients
Treatment
? Pre-antibiotic era - a death sentence
? Antibiotic era
- microbiologic cure in majority of patients
New Treatments
? Right-sided infective endocarditis due to methicillin-susceptible S aureus (MSSA) in IV drug users
- 2-wk therapy with a penicillinase-resistant penicillin and an aminoglycoside
- 2-wk monotherapy with IV cloxacillin
- short-term therapy is inappropriate if complicated by ostomyelitis, meningitis, myocardial abscess, or concomitant left-sided involvement
New Treatments
? Highly penicillin-susceptible Streptococcus viridans or bovis
- Once-daily ceftriaxone for 4 wks
? cure rate > 98%
? easily administered as outpatient, avoid hospitalization, offers significant cost savings
- Once-daily ceftriaxone 2 g for 2wks followed by oral amoxicillin qid for 2 wks
- Once-daily ceftriazone and netilmicin for 2 wks
New Treatments
? Prosthetic valve endocarditis due to fluconazole-susceptible Candida species
- many are due to bloodstream invasion
- chronic oral suppressive therapy with fluconazole for inoperable disease
SBE Prophylaxis
Standard general prophylaxisamoxicillin
Unable to take oral medsampicillin
Allergic to penicilinclindamycin
cephalexin
azithromycin
clarithromycin
Allergic to penicillin and unableclindamycin
to take oral medicationscefazolin
References
? Prevention of bacterial endocarditis.Recommended by the American Heart Association.
Dajani AS, Taubert KA, Wilson W, et al. Circulation 1997;96:358-366
? New Criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings.
Durack DT, Lukes AS, Bright DK, et al.Am J Med 1994;96:200-209
? Antibiotic treatment of adults with infective endocarditis due to strptococci, enterococci, staphlococci, and HACEK microorganisms.Wilson WR, Karchmer AW, Dajani AS. JAMA 1995;274:1706-1713
附件资料：
相关资料1：
- 复方中药制剂“球宁”对感染柔嫩艾美耳球虫雏鸡红细胞免疫功能的影响.pdf
- 幽门螺杆菌感染免疫预防研究的现状与进展.pdf
- 预防上睑埋线术后感染的体会.pdf
- 血管内导管相关感染的预防与治疗指南_2007_.pdf
- HIV感染母婴传播途径、时机和影响因素.pdf
- 《感染》史考特·席格勒.pdf .mobi
- 非感染性尿道综合征辨治心得.pdf
- 新型冠状病毒感染防护.mobi
- 血管外肺水指数对感染性休克患者预后的评价.pdf
- 成人严重感染与感染性休克血流动力学监测与支持指南_2006_.pdf
- 肠瘘及肠功能障碍并腹腔感染的治疗策略.pdf
- 解读侵袭性肺部真菌感染的诊断标准与治疗原则（ 草案）.pdf
- 《新型冠状病毒感染防护》.pdf .epub .mobi .azw3
- 国内外呼吸系统感染性疾病诊治指南及其理念.pdf
- 肺部真菌感染的抗原检测技术及临床意义.pdf
相关资料2：